VBI Vaccines Inc

$3.02 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About VBI Vaccines Inc

VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).

Stock Analysis

last close $3.02
1-mo return -4.4%
3-mo return 2.4%
avg daily vol. 1.63M
52-week high 4.83
52-week low 2.07
market cap. $763M
forward pe -
annual div. -
roe -42.7%
ltg forecast -
dividend yield -
annual rev. $1M
inst own. 50%
baraka

Subscribe now for daily local and international financial news

Subscribe